Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.blissgvs.com | |
Market Cap | 1,486.35 Cr. | |
Enterprise Value(EV) | 1,407.98 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 8.43 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 16.84 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.73 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 88.96 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.60 | Calculated using Price: 142.00 |
Dividend Yield | 0.35 | Period Ending 2023-03 |
No. of Shares Subscribed | 10.47 Cr. | 104,672,822 Shares |
FaceValue | 1 | |
About Bliss GVS Pharma Ltd. | ||
It is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. The company's most unique product is ‘Today Vaginal Contraceptive', a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception. Bliss also manufactures to US specification vaginal pessaries of Clotrimazole & Povidone Iodine in addition to Anal Suppositories for treatment of piles. The company also manufacture wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products. |
1 Day |
|
+0.35% |
1 Week |
|
-2.80% |
1 Month |
|
+41.82% |
3 Month |
|
+46.95% |
6 Month |
|
+94.60% |
1 Year |
|
+93.14% |
2 Year |
|
+40.91% |
5 Year |
|
-2.07% |
10 Year |
|
+269.48% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 19.74 | 26.73 | 25.06 | 17.34 | 21.43 | 13.79 | 9.64 | 2.88 | 9.11 | |
Return on Capital Employed (%) | 23.57 | 32.07 | 31.06 | 24.61 | 26.58 | 17.02 | 12.49 | 6.37 | 12.22 | |
Return on Assets (%) | 9.01 | 13.04 | 11.88 | 9.42 | 14.35 | 9.86 | 7.03 | 2.12 | 6.78 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 337 | 413 | 487 | 536 | 646 | 736 | 808 | 819 | 884 | 930 | |
Non Curr. Liab. | 68 | 50 | 33 | 13 | 38 | 46 | 45 | 29 | 43 | 62 | |
Curr. Liab. | 243 | 379 | 437 | 299 | 207 | 231 | 204 | 233 | 193 | 172 | |
Minority Int. | 15 | 33 | 66 | 11 | 14 | 15 | 20 | 28 | 34 | 33 | |
Equity & Liab. | 662 | 874 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,154 | 1,197 | |
Non Curr. Assets | 245 | 291 | 457 | 170 | 211 | 257 | 312 | 332 | 456 | 451 | |
Curr. Assets | 417 | 583 | 566 | 690 | 693 | 770 | 765 | 777 | 697 | 747 | |
Misc. Exp. not W/O | 0 | ||||||||||
Total Assets | 662 | 874 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,154 | 1,197 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 407 | 547 | 798 | 815 | 899 | 689 | 577 | 747 | 752 | 762 | |
Other Income | 20 | 24 | 13 | 27 | 38 | 39 | 22 | 31 | 18 | 26 | |
Total Income | 427 | 571 | 811 | 841 | 936 | 728 | 599 | 779 | 769 | 788 | |
Total Expenditure | -304 | -391 | -596 | -618 | -741 | -566 | -471 | -629 | -634 | -629 | |
PBIDT | 124 | 180 | 215 | 224 | 195 | 163 | 129 | 150 | 135 | 159 | |
Interest | -16 | -19 | -20 | -23 | -4 | -8 | -7 | -5 | -10 | -9 | |
Depreciation | -11 | -13 | -20 | -21 | -9 | -13 | -17 | -17 | -19 | -22 | |
Taxation | -35 | -48 | -63 | -57 | -55 | -34 | -30 | -31 | -29 | -37 | |
Exceptional Items | -34 | -13 | -74 | ||||||||
PAT | 61 | 100 | 113 | 89 | 127 | 95 | 74 | 23 | 77 | 91 | |
Minority Interest | -1 | -18 | -31 | -30 | -3 | 2 | -5 | -8 | -6 | -2 | |
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 60 | 82 | 82 | 59 | 124 | 97 | 68 | 15 | 71 | 88 | |
Adjusted EPS | 6 | 8 | 8 | 6 | 12 | 9 | 7 | 1 | 7 | 8 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 41 | 38 | 113 | 289 | 18 | 40 | 47 | 64 | 135 | 34 | |
Cash Fr. Inv. | -11 | -29 | -50 | -231 | 50 | -74 | -48 | -47 | -93 | -8 | |
Cash Fr. Finan. | -8 | -42 | -40 | -10 | -76 | 17 | -6 | -21 | -24 | -25 | |
Net Change | 22 | -33 | 23 | 48 | -8 | -17 | -8 | -4 | 19 | 2 | |
Cash & Cash Eqvt | 50 | 5 | 28 | 47 | 37 | 15 | 15 | 13 | 22 | 25 |
Fri, 03 Nov 2023
Copy of Newspaper Publication
|
|
Thu, 02 Nov 2023
Outcome of Board Meeting
|
|
Thu, 02 Nov 2023
Financial Result Updates
|
Mon, 04 Dec 2023 |
|
|
|
|
|